A detailed history of Quadrant Capital Group LLC transactions in Galapagos Nv stock. As of the latest transaction made, Quadrant Capital Group LLC holds 11,268 shares of GLPG stock, worth $314,377. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,268
Previous 6,549 72.06%
Holding current value
$314,377
Previous $162,000 100.0%
% of portfolio
0.02%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$24.2 - $30.67 $114,199 - $144,731
4,719 Added 72.06%
11,268 $324,000
Q2 2024

Aug 12, 2024

BUY
$24.78 - $32.48 $116,837 - $153,143
4,715 Added 257.09%
6,549 $162,000
Q1 2024

May 15, 2024

BUY
$32.2 - $42.44 $4,121 - $5,432
128 Added 7.5%
1,834 $59,000
Q4 2023

Feb 08, 2024

BUY
$31.87 - $40.71 $8,318 - $10,625
261 Added 18.06%
1,706 $69,000
Q3 2023

Nov 14, 2023

BUY
$34.17 - $42.98 $1,708 - $2,149
50 Added 3.58%
1,445 $49,000
Q2 2023

Aug 09, 2023

BUY
$37.4 - $44.52 $45,927 - $54,670
1,228 Added 735.33%
1,395 $56,000
Q1 2023

May 11, 2023

BUY
$36.5 - $48.0 $5,584 - $7,344
153 Added 1092.86%
167 $6,000
Q4 2022

Feb 10, 2023

SELL
$37.44 - $46.51 $13,253 - $16,464
-354 Reduced 96.2%
14 $0
Q3 2022

Nov 10, 2022

SELL
$42.27 - $57.6 $8,580 - $11,692
-203 Reduced 35.55%
368 $16,000
Q2 2022

Aug 09, 2022

BUY
$52.3 - $71.59 $7,112 - $9,736
136 Added 31.26%
571 $32,000
Q1 2022

May 06, 2022

BUY
$51.32 - $68.5 $2,668 - $3,562
52 Added 13.58%
435 $27,000
Q4 2021

Feb 01, 2022

BUY
$47.03 - $57.12 $8,841 - $10,738
188 Added 96.41%
383 $21,000
Q3 2021

Nov 12, 2021

SELL
$52.17 - $70.2 $19,876 - $26,746
-381 Reduced 66.15%
195 $10,000
Q2 2021

Aug 09, 2021

BUY
$68.86 - $83.34 $32,777 - $39,669
476 Added 476.0%
576 $40,000
Q1 2021

May 12, 2021

BUY
$76.15 - $111.94 $4,340 - $6,380
57 Added 132.56%
100 $8,000
Q4 2020

Feb 16, 2021

SELL
$96.85 - $148.25 $484 - $741
-5 Reduced 10.42%
43 $4,000
Q3 2020

Nov 13, 2020

SELL
$122.47 - $213.56 $6,490 - $11,318
-53 Reduced 52.48%
48 $7,000
Q2 2020

Aug 13, 2020

BUY
$185.52 - $231.25 $2,040 - $2,543
11 Added 12.22%
101 $20,000
Q1 2020

May 15, 2020

BUY
$143.0 - $274.03 $2,145 - $4,110
15 Added 20.0%
90 $17,000
Q4 2019

Feb 03, 2020

BUY
$146.12 - $215.82 $10,959 - $16,186
75 New
75 $15,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.84B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.